
# GAIA 2.0: Gap Research Report R#8.1–R#8.20 — Human Superpowers Database
## Blueprint 70: Empirical Validation of the Human Superpowers Architecture
### September 9, 2026 — Version 1.0

---

> *"No jurisdiction has devised governance commensurate with the technology's capacity to read from, and write to, the human nervous system."*
> — "Governing Brain-Computer Interfaces: The Categorical Gap Hypothesis" (Neurotechnology, Society & Governance, 2026)

> *"The highest VO2 max ever recorded is 101.1 mL/kg/min, achieved by Norwegian triathlete Kristian Blummenfelt in early 2026 — the first athlete to break the 100 barrier, a number once considered physiologically impossible."*
> — ScienceInsights (May 2026)

> *"Genuine amplification — where AI improves hybrid performance while preserving human expertise — remains elusive. No tested regime achieves CAI* > 0."*
> — "Cognitive Amplification vs Cognitive Delegation" (arXiv:2603.18677, March 2026)

---

## EXECUTIVE SUMMARY

This blueprint addresses 20 critical gaps in the GAIA 2.0 Human Superpowers Database architecture. The research reveals a landscape of **extraordinary documented human performance** (VO2 max 101.1; ultra-endurance 16,104 kcal expenditure), **emerging governance crises** (BCI categorical gap across 34 jurisdictions), and **a critical warning** about human-AI amplification: current AI interaction designs may be causing cognitive delegation rather than genuine amplification.

**Priority Tier 1 — Critical Findings:**

| Gap | Key Finding | Action Required |
|-----|-------------|-----------------|
| R#8.2 Evidence | Oxford hierarchy: Meta-analysis > RCT > Observational; confidence scoring required | Implement 5-level evidence scoring for all superpower claims |
| R#8.9 BCI Governance | Categorical Gap Hypothesis: 34 jurisdictions; no adequate governance exists | GAIAN must implement neurorights protection before BCI integration |
| R#8.10 BCI Architecture | Neural privacy is unprotected; brain data governance BD0-BD3 framework | Adopt BD3 (highest protection) for all GAIAN neural data |
| R#8.11 Longevity | Nature Medicine 2026: 51 studies; DunedinPACE most responsive; pharmacological > lifestyle | GAIAN longevity tracking uses generation 2+ epigenetic clocks |
| R#8.18 Amplification | CAI* < 0 in all tested regimes; cognitive delegation risk is real | GAIAN must maximize CAI*; minimize cognitive delegation |

**Critical Warning**: The Cognitive Amplification Index (CAI*) research (March 2026) finds that **no current human-AI interaction regime achieves genuine amplification** — all tested configurations show CAI* < 0, meaning AI assistance may be degrading human capability over time. GAIA 2.0 must design GAIAN to maximize CAI* and minimize cognitive delegation.

---

## PART I: TIER 1 — CRITICAL GAPS

### R#8.2 Evidence Hierarchy and Validation

```
RESEARCH FINDINGS: EVIDENCE HIERARCHY

KEY FINDING: OXFORD HIERARCHY + CONFIDENCE SCORING REQUIRED
─────────────────────────────────────────────────────────────────
OXFORD EVIDENCE HIERARCHY (Standard):
─────────────────────────────────────────────────────────────────
Level 1a: Systematic reviews of RCTs (highest)
Level 1b: Individual RCTs with narrow confidence intervals
Level 2a: Systematic reviews of cohort studies
Level 2b: Individual cohort studies; low-quality RCTs
Level 3a: Systematic reviews of case-control studies
Level 3b: Individual case-control studies
Level 4: Case series; poor-quality cohort/case-control
Level 5: Expert opinion; animal studies; first principles (lowest)

GAIA 2.0 SUPERPOWER EVIDENCE SCORING:
─────────────────────────────────────────────────────────────────
SuperpowerEvidenceScore {
  evidence_level: Int         // 1-5 (Oxford hierarchy)
  study_count: Int            // Number of studies
  sample_size: Int            // Total participants
  replication_status: String  // Replicated / Single study / Unreplicated
  human_vs_animal: String     // Human / Animal / In vitro
  clinical_status: String     // Clinical / Experimental / Theoretical
  confidence: Float           // 0.0-1.0
  
  label: String               // "Established" / "Promising" / "Experimental" / "Speculative" / "Theoretical"
}

5-LABEL CONFIDENCE CLASSIFICATION:
─────────────────────────────────────────────────────────────────
ESTABLISHED (Level 1-2; replicated; human; clinical):
  Examples: VO2 max training; deliberate practice; flow state
  GAIAN: "This is well-established science"

PROMISING (Level 2-3; some replication; human; experimental):
  Examples: Working memory training; meditation effects; cold exposure
  GAIAN: "This shows promise but needs more research"

EXPERIMENTAL (Level 3-4; limited replication; mixed human/animal):
  Examples: Nootropics; some BCI applications; gene therapy
  GAIAN: "This is experimental — proceed with caution"

SPECULATIVE (Level 4-5; single studies; animal models):
  Examples: Most genetic enhancement; some longevity interventions
  GAIAN: "This is speculative — not ready for human application"

THEORETICAL (Level 5; no human studies; first principles):
  Examples: Mind uploading; radical life extension; neural lace
  GAIAN: "This is theoretical — decades from human application"

FUTURE-CLAIM PROBABILITY ASSESSMENT:
─────────────────────────────────────────────────────────────────
Technology Readiness Level (TRL) 1-9:
TRL 1-3: Basic research (theoretical)
TRL 4-6: Development (experimental)
TRL 7-8: Demonstration (promising)
TRL 9: Deployment (established)

GAIAN: Reports TRL for all future superpower claims
Example: "Neural lace: TRL 2 — basic research phase; estimated 20+ years to deployment"

EVIDENCE TRANSPARENCY REQUIREMENTS:
─────────────────────────────────────────────────────────────────
GAIAN: Always shows evidence score for superpower claims
User: Can drill down to see underlying studies
Conflicts: Multiple studies with conflicting results shown
Uncertainty: Confidence intervals always reported
```

### R#8.9 Human Augmentation Governance

```
RESEARCH FINDINGS: AUGMENTATION GOVERNANCE

KEY FINDING: CATEGORICAL GAP HYPOTHESIS — NO JURISDICTION HAS ADEQUATE BCI GOVERNANCE
─────────────────────────────────────────────────────────────────
Source: "Governing Brain-Computer Interfaces: The Categorical Gap Hypothesis
and a Five-Dimensional Global Typology of Neurotechnology Governance (2010-2026)"
Neurotechnology, Society & Governance, Vol. 1, No. 1 (2026)
Author: Changkui Li (Hong Kong Center of Social Sciences)
Published: March 1, 2026

CATEGORICAL GAP HYPOTHESIS:
─────────────────────────────────────────────────────────────────
"Jurisdictions relying on inherited regulatory categories will systematically
underperform in protecting mental privacy, allocating responsibility, and
enforcing neurorights in non-clinical BCI deployments."

34 jurisdictions mapped
4 governance regimes identified:
1. Risk-containment: Focuses on safety; ignores neurorights
2. Rights-constitutionalization: Recognizes neurorights (Chile; Colorado)
3. Market-mediated soft governance: Industry self-regulation
4. Security-exceptionalism: National security overrides rights

FIVE-DIMENSIONAL CODING SCHEME (D1-D5):
─────────────────────────────────────────────────────────────────
D1: Regulatory-object definition (what counts as a BCI?)
D2: Neurorights recognition (L0-L3):
    L0: No recognition
    L1: Soft recognition (guidelines)
    L2: Statutory recognition
    L3: Constitutional recognition (Chile; Colorado)
D3: Responsibility allocation (who is liable?)
D4: Brain data governance (BD0-BD3):
    BD0: No specific protection
    BD1: General data protection applies
    BD2: Sensitive data category
    BD3: Highest protection (neural-specific)
D5: Enforcement survivability (can rules be enforced?)

NEURORIGHTS FRAMEWORK:
─────────────────────────────────────────────────────────────────
Source: "Advancing data protections for implantable brain-computer interfaces"
Nature Communications Medicine (2026)
Authors: Julian D. Sandbrink et al.

5 Neurorights (Neurorights Foundation):
1. Mental privacy: Right to protect neural data
2. Mental integrity: Right to protection from neural manipulation
3. Psychological continuity: Right to preserve personal identity
4. Cognitive liberty: Right to choose cognitive enhancement
5. Equal access to mental augmentation: Right to fair access

GAIA 2.0 BCI GOVERNANCE POSITION:
─────────────────────────────────────────────────────────────────
GAIAN Constitution (Blueprint 39): Invariant 0.2 — GAIAN belongs to human
Extension: Neural data is the most intimate data — highest protection required
GAIAN: Adopts BD3 (highest protection) for all neural data
Neurorights: All 5 neurorights protected by GAIAN design
Consent: Explicit, informed, revocable consent for all neural data

ENHANCEMENT EQUITY POLICIES:
─────────────────────────────────────────────────────────────────
Risk: BCI enhancement creates cognitive inequality
GAIA 2.0: Advocates for equal access to cognitive enhancement
GAIAN: Tracks enhancement equity; flags inequality risks
Policy: GAIA 2.0 Foundation advocates for neurorights legislation

CONSENT STANDARDS:
─────────────────────────────────────────────────────────────────
Neural data consent: Highest standard (beyond GDPR)
Revocable: User can withdraw consent at any time
Granular: Consent per data type; per use case
Transparent: User sees exactly what neural data is collected
GAIAN: Never collects neural data without explicit consent
```

### R#8.10 Brain-Computer Interface Architecture

```
RESEARCH FINDINGS: BCI ARCHITECTURE

KEY FINDING: CATEGORICAL GAP + NEURAL PRIVACY CRISIS
─────────────────────────────────────────────────────────────────
Source: "Regulating Next-Generation Implantable Brain-Computer Interfaces:
Recommendations for Ethical Development and Implementation"
Neuroethics (Springer, 2026)

BCI LANDSCAPE 2026:
─────────────────────────────────────────────────────────────────
Non-invasive BCIs: EEG headsets; fNIRS; consumer devices
Minimally invasive: Stentrode (endovascular); ECoG
Fully invasive: Neuralink N1; BrainGate; Utah Array
Commercial deployment: BCIs have crossed into commercial deployment

COGNITIVE BANDWIDTH MEASUREMENT:
─────────────────────────────────────────────────────────────────
Current BCIs: ~1-10 bits/second (non-invasive)
Neuralink N1: ~1,000 bits/second (invasive)
Human speech: ~40 bits/second
Human thought: ~10-100 bits/second (estimated)
Future target: 1,000,000 bits/second (theoretical)

NEURAL PRIVACY PROTECTIONS:
─────────────────────────────────────────────────────────────────
Brain data: Most sensitive data type (reveals thoughts; emotions; health)
Current protection: Inadequate (BD0-BD1 in most jurisdictions)
Required protection: BD3 (neural-specific; highest)
GAIAN: Implements BD3 for all neural data
Encryption: AES-256-GCM for neural data at rest
Transmission: TLS 1.3 + additional neural-specific encryption

BIDIRECTIONAL COMMUNICATION SYSTEMS:
─────────────────────────────────────────────────────────────────
Read: Neural signals → digital data (current BCIs)
Write: Digital signals → neural stimulation (emerging)
Risk: Write capability enables manipulation
GAIAN: Read-only by default; write requires explicit consent + safety validation
Constitutional constraint: GAIAN cannot manipulate user's neural state

MEMORY AUGMENTATION PROTOCOLS:
─────────────────────────────────────────────────────────────────
Current: External memory aids (notes; reminders)
Near-term: Neural-linked memory retrieval (BCI-assisted)
Future: Direct memory encoding (theoretical; TRL 2)
GAIAN: Supports external memory augmentation now; BCI integration when safe

SAFETY MONITORING SYSTEMS:
─────────────────────────────────────────────────────────────────
Invasive BCIs: Infection risk; electrode degradation; tissue response
Non-invasive BCIs: Minimal physical risk; privacy risk
GAIAN: Monitors BCI safety; alerts to anomalies
Certification: Only FDA/CE-cleared BCIs integrated with GAIAN
```

### R#8.11 Longevity Science Integration

```
RESEARCH FINDINGS: LONGEVITY SCIENCE

KEY FINDING: NATURE MEDICINE 2026 — 51 STUDIES; DUNEDINPACE MOST RESPONSIVE
─────────────────────────────────────────────────────────────────
Source: "Responsiveness of epigenetic aging biomarkers to longevity
interventions in humans"
Nature Medicine (2026)
DOI: 10.1038/s41591-026-04562-9
Database: TranslAGE (51 longitudinal intervention studies)
Biomarkers: 16 epigenetic clocks; 94 DNAm biomarkers

KEY FINDINGS:
─────────────────────────────────────────────────────────────────
Most responsive clocks: Generation 2+ (DunedinPACE; PCGrimAge; GrimAgeV2; PCPhenoAge; SystemsAge)
DunedinPACE: Greatest overall responsiveness to intervention-associated changes
PCGrimAge: Strongest statistical evidence of responsiveness

Intervention effectiveness:
- Pharmacological: Largest effects on DNAm biomarkers
- Lifestyle: Strong responses (Mediterranean diet; exercise)
- Supplements: Variable responses
- Medical procedures: Variable responses

19 interventions: Significantly decreased DNAm aging measures
5 interventions: Significantly increased DNAm aging measures

Strongest pharmacological effects:
- TNF-targeting agents (arthritis; IBD): Modified almost all 2nd-gen biomarkers
- Metformin: Strong changes in DNAm biomarkers
- Mechanism: Inflammatory + metabolic pathways (AMPK; mTOR; TNF)

BIOLOGICAL AGE MEASUREMENT:
─────────────────────────────────────────────────────────────────
Source: "Biological age clocks: Validated and questioned in the same quarter"
Journal of Precision Medicine (June 2026)

Generation 1 clocks: Horvath; Hannum (predict chronological age)
Generation 2 clocks: PhenoAge; GrimAgeV1; DunedinPACE (predict mortality/pace)
Generation X (explainable): OMICmAge; DNAmEMRAge; SystemsAge

GAIAN longevity tracking: Generation 2+ clocks (most responsive)
Recommended: DunedinPACE (pace of aging) + PCGrimAge (mortality risk)

COMBINATION THERAPY EFFECTS:
─────────────────────────────────────────────────────────────────
Mediterranean diet: Decreased 2nd-gen biomarkers in healthy individuals
Senolytic studies: Divergent changes (inconsistent effects)
TNF + metformin: Not yet studied in combination
GAIAN: Tracks combination effects; alerts to potential interactions

LONGEVITY ACCESSIBILITY:
─────────────────────────────────────────────────────────────────
Epigenetic testing: ~$300-500 (TruDiagnostic; Elysium; etc.)
Metformin: Generic; ~$10/month
Mediterranean diet: Accessible; low cost
GAIAN: Prioritizes accessible interventions; flags cost barriers

CAUTION:
─────────────────────────────────────────────────────────────────
"Responsiveness alone does not establish a DNAm biomarker as a valid
surrogate endpoint or show that an intervention slows aging."
GAIAN: Always includes this caveat when discussing longevity interventions
```

### R#8.18 Human-AI Amplification Science

```
RESEARCH FINDINGS: HUMAN-AI AMPLIFICATION

KEY FINDING: CAI* < 0 IN ALL TESTED REGIMES — COGNITIVE DELEGATION RISK IS REAL
─────────────────────────────────────────────────────────────────
Source: "Cognitive Amplification vs Cognitive Delegation in Human-AI Systems:
A Metric Framework"
arXiv:2603.18677 (March 2026; v2)
Author: Eduardo Di Santi (University of Colorado Boulder)
License: CC BY 4.0

FOUR OPERATIONAL METRICS:
─────────────────────────────────────────────────────────────────
1. CAI* (Cognitive Amplification Index):
   Quantifies genuine collaborative gain beyond the best standalone agent
   CAI* > 0: Genuine amplification (human+AI > best of human or AI alone)
   CAI* < 0: Delegation (human+AI ≤ best standalone)

2. DD (Dependency Ratio):
   Measures structural dominance of AI within hybrid output
   DD > 1: AI dominates (cognitive delegation)
   DD < 1: Human leads (cognitive amplification)

3. HRI (Human Reliance Index):
   Measures degree of human reliance on AI
   High HRI: Human cannot function without AI

4. HCDR (Human Cognitive Drift Rate):
   Captures temporal erosion of autonomous human cognitive performance
   Positive HCDR: Human capability improving
   Negative HCDR: Human capability degrading (atrophy)

CRITICAL FINDING:
─────────────────────────────────────────────────────────────────
"Across all tested configurations, no regime achieves genuine amplification:
mixed reliance preserves substantially more human capability than full
delegation, but still exhibits CAI* < 0 and D > 1."

"Reducing atrophy monotonically improves retained human capability,
collaborative gain, and dependency structure, but even zero atrophy does
not yield positive collaborative gain."

"Capability preservation alone is insufficient to recover genuine
amplification under the present interaction dynamics."

IMPLICATIONS FOR GAIA 2.0:
─────────────────────────────────────────────────────────────────
Current AI assistance designs → cognitive delegation, not amplification
GAIAN must be designed to maximize CAI* (genuine amplification)
Key design principles:
1. Preserve human capability (minimize HCDR)
2. Reduce dependency (minimize DD)
3. Maximize collaborative gain (maximize CAI*)
4. Monitor cognitive drift (track HCDR over time)

GAIA 2.0 AMPLIFICATION ARCHITECTURE:
─────────────────────────────────────────────────────────────────
GAIAN design principle: "I amplify you; I do not replace you"
Cognitive preservation: GAIAN encourages human reasoning, not just answers
Dependency monitoring: GAIAN tracks user's dependency ratio
Drift detection: GAIAN alerts when human capability is declining
Scaffolding: GAIAN provides scaffolding that fades as human capability grows

EXPERTISE-AMPLIFICATION RELATIONSHIPS:
─────────────────────────────────────────────────────────────────
Source: "AI as Equalizer or Amplifier? Task Complexity as the Moderating
Factor for Human Expertise in Hybrid Intelligence Systems" (arXiv:2512.10961)
Key finding: AI amplifies experts more than novices on complex tasks
GAIAN: Adapts amplification strategy based on user expertise level

PRODUCTIVITY GAIN TRACKING:
─────────────────────────────────────────────────────────────────
Source: Global AI Productivity Impact Report 2026 (Alice Labs)
Key finding: AI productivity gains are real but unevenly distributed
GAIAN: Tracks user's productivity gains; identifies where AI helps most
```

---

## PART II: TIER 2 — HIGH VALUE GAPS

### R#8.3 Human Potential Modeling

```
RESEARCH FINDINGS: HUMAN POTENTIAL MODELING

KEY FINDING: GENE-ENVIRONMENT INTERACTIONS ARE COMPLEX; AI-DRIVEN MULTI-OMICS IS EMERGING
─────────────────────────────────────────────────────────────────
Source: "A cross-population compendium of gene-environment interactions"
Nature (January 28, 2026)
Authors: Shinichi Namba, Kyuto Sonehara, et al.

Source: "AI-driven multi-omics integration for multi-scale predictive
modeling of genotype-environment-phenotype relationships"
Computational and Structural Biotechnology Journal (2025)

GENETIC CONTRIBUTION MODELS:
─────────────────────────────────────────────────────────────────
VO2 max: ~50% heritable (twin studies)
Intelligence: ~50-80% heritable (adult twin studies)
Athletic performance: Complex polygenic; environment critical
Longevity: ~25% heritable; environment dominates

Key genetic variants for performance:
- EPAS1: High-altitude adaptation (Tibetan populations)
- MSTN: Myostatin deficiency → increased muscle mass (trade-offs exist)
- ACTN3: R577X variant → fast-twitch muscle fiber composition
- ACE: I/D polymorphism → endurance vs. power performance

ENVIRONMENTAL CONTRIBUTION MODELS:
─────────────────────────────────────────────────────────────────
Training: Can improve VO2 max 15-20% in untrained individuals
Nutrition: Critical for performance optimization
Sleep: 8+ hours → significant performance gains
Stress: Chronic stress → performance degradation
Social environment: Coaching; community; competition

TRAINING RESPONSE PREDICTION:
─────────────────────────────────────────────────────────────────
Source: "The DNA of Fit-Tech: optimizing physical performance through
genetic analysis and AI-driven exercise planning" (IJSRA, 2025)
AI-driven personalization: Genetic + biometric + training data → optimal plan
GAIAN: Personalizes training recommendations based on genetic profile (with consent)

DEVELOPMENT TRAJECTORY FORECASTING:
─────────────────────────────────────────────────────────────────
Evo 2 (Nature, March 4, 2026): Genome modelling across all domains of life
Application: Predict phenotype from genotype + environment
GAIAN: Uses multi-omics data to forecast development trajectories
Caveat: Predictions are probabilistic; environment matters enormously
```

### R#8.4 Trainability Science

```
RESEARCH FINDINGS: TRAINABILITY SCIENCE

KEY FINDING: DELIBERATE PRACTICE IS REAL; BIOLOGICAL LIMITS ARE REAL
─────────────────────────────────────────────────────────────────
BIOLOGICAL LIMITS OF TRAINING:
─────────────────────────────────────────────────────────────────
VO2 max ceiling: ~101.1 mL/kg/min (Blummenfelt, 2026) — first to break 100
Neural signal speed: ~120 m/s (myelinated axons) — fixed by electrochemistry
Muscle fiber composition: ~50% determined by genetics
Bone density: Trainable but limited by genetics and age
Cognitive processing speed: Limited by neural architecture

DELIBERATE PRACTICE REQUIREMENTS:
─────────────────────────────────────────────────────────────────
Ericsson's deliberate practice:
- 10,000 hours: Rough estimate for expert performance (domain-dependent)
- Focused practice: At edge of ability; not comfortable repetition
- Immediate feedback: Essential for improvement
- Expert guidance: Significantly accelerates development

RETENTION AND DECAY RATES:
─────────────────────────────────────────────────────────────────
Physical fitness: Detraining begins within 2 weeks
Cognitive skills: Slower decay; but still present
Motor skills: Very slow decay (procedural memory)
GAIAN: Tracks skill decay; schedules maintenance practice

ACCELERATED LEARNING METHODS:
─────────────────────────────────────────────────────────────────
Spaced repetition: Optimal review intervals (Ebbinghaus)
Interleaved practice: Mix of skills → better transfer
Sleep consolidation: Sleep after learning → better retention
Retrieval practice: Testing > re-reading for retention
GAIAN: Implements all four methods in learning recommendations
```

### R#8.5 Cognitive Enhancement Research

```
RESEARCH FINDINGS: COGNITIVE ENHANCEMENT

KEY FINDING: WORKING MEMORY TRAINING SHOWS REAL GAINS; TRANSFER IS LIMITED
─────────────────────────────────────────────────────────────────
Source: "Meta-analysis of computerised working memory training: behavioural
gains, training parameters, transfer mechanisms, and neural correlates"
npj Digital Medicine (March 12, 2026)

KEY FINDINGS:
─────────────────────────────────────────────────────────────────
Working memory training: Real behavioural gains (confirmed by meta-analysis)
Near transfer: Strong (similar tasks improve)
Far transfer: Limited (different tasks show less improvement)
Neural correlates: Confirmed (brain plasticity changes)

Source: "Domain-general behavioral gains and neural correlates of cognitive
training in healthy populations: a neuroimaging meta-analysis"
Behavioral and Brain Functions (2026)

Domain-general gains: Some cognitive training shows broad benefits
Neural correlates: Prefrontal cortex; parietal cortex; hippocampus

NEUROPLASTICITY ACCELERATION:
─────────────────────────────────────────────────────────────────
Source: "The neuroplastic brain: current breakthroughs and emerging frontiers"
Brain Research (July 2025)

Key mechanisms:
- Long-term potentiation (LTP): Synaptic strengthening
- Neurogenesis: New neuron formation (hippocampus)
- Myelination: Faster signal transmission
- Synaptic pruning: Efficiency improvement

Accelerators:
- Physical exercise: BDNF release → neurogenesis
- Sleep: Memory consolidation; synaptic homeostasis
- Novelty: New experiences → new connections
- Mindfulness: Structural brain changes (gray matter)

COGNITIVE PERFORMANCE CEILINGS:
─────────────────────────────────────────────────────────────────
Working memory: ~7±2 items (Miller's Law) — trainable but limited
Processing speed: Limited by neural architecture
Attention: Trainable; but multitasking is a myth
GAIAN: Honest about cognitive ceilings; focuses on optimization within limits
```

### R#8.6 Flow State Science

```
RESEARCH FINDINGS: FLOW STATE SCIENCE

KEY FINDING: FLOW = DMN SUPPRESSION + ECN ENGAGEMENT; WEARABLE MEASUREMENT FEASIBLE
─────────────────────────────────────────────────────────────────
Source: "Enhanced functional connectivity between the default mode network
and executive control network during flow states may facilitate creativity
and emotional regulation"
Frontiers in Behavioral Neuroscience (2026)
PRISMA systematic review; 9 studies included

NEUROLOGICAL SIGNATURE OF FLOW:
─────────────────────────────────────────────────────────────────
1. DMN down-regulation: Reduced self-referential thought
   (medial prefrontal cortex; posterior cingulate cortex)
2. ECN activation: Increased attentional control
   (lateral prefrontal; parietal areas)
3. DMN-ECN connectivity: Anti-correlated networks become connected
4. Amygdala reduction: Low anxiety; emotional stability
5. Insula-reward coupling: Intrinsic motivation

FLOW INDUCTION METHODS:
─────────────────────────────────────────────────────────────────
Challenge-skill balance: Task difficulty = skill level (Csikszentmihalyi)
Clear goals: Unambiguous objectives
Immediate feedback: Real-time performance information
Elimination of distractions: Environmental control
Intrinsic motivation: Task must be inherently meaningful

WEARABLE MEASUREMENT:
─────────────────────────────────────────────────────────────────
Source: "Physiological assessment of the psychological flow state using
wearable devices" (Scientific Reports, April 7, 2025)
Authors: Melinda Rácz, Melinda Becske, et al.

Wearable indicators of flow:
- Heart rate variability (HRV): Increases during flow
- Skin conductance: Moderate arousal
- EEG (consumer): Alpha/theta waves
- Eye tracking: Reduced blink rate; focused gaze

GAIAN: Monitors wearable data for flow state indicators
Alert: "You appear to be in flow — I'll minimize interruptions"

REAL-TIME FLOW TRACKING:
─────────────────────────────────────────────────────────────────
Source: "Tracking Flow in Real Time: Continuous Measurement of Game-Induced
Flow in Virtual Reality" (Psychophysiology, 2026)
Key finding: Continuous flow measurement is feasible in VR
GAIAN: Adapts interaction style based on detected flow state

TEAM FLOW EMERGENCE:
─────────────────────────────────────────────────────────────────
Team flow: Collective flow state in groups
Conditions: Shared goals; complementary skills; open communication
GAIAN: Supports team flow through coordination and communication tools
```

### R#8.7 Exceptional Human Performance Database

```
RESEARCH FINDINGS: EXCEPTIONAL HUMAN PERFORMANCE

KEY FINDING: DOCUMENTED UPPER LIMITS OF HUMAN PERFORMANCE
─────────────────────────────────────────────────────────────────
AEROBIC PERFORMANCE:
─────────────────────────────────────────────────────────────────
VO2 max record: 101.1 mL/kg/min (Kristian Blummenfelt, 2026)
  - First human to break 100 barrier
  - Previous record: 97.5 mL/kg/min (Oskar Svendsen, 2012)
  - Average untrained male 20s: 35-45 mL/kg/min
  - "Superior" (95th percentile) male 20s: 58.5 mL/kg/min

Ultra-endurance limits (2025 Western States 100):
  - Total energy expenditure: 16,104 kcal (18.8 kcal/min peak)
  - Carbohydrate intake: 86 g/hour (upper sustainable limit)
  - Fluid intake: 12.5 L (0.87 L/hour)
  - Body mass loss: 4.3%
  - Gastrointestinal temperature peak: 39.4°C
  - Pacing: 84.8% of critical speed; 15% decline across race

GENETIC OUTLIERS:
─────────────────────────────────────────────────────────────────
EPAS1 (Tibetan adaptation): Lower hemoglobin at altitude; healthier
MSTN deficiency: Dramatically increased muscle mass (trade-offs exist)
ACTN3 R577X: Fast-twitch fiber composition → power performance
LRP5 G171V: High bone density → fracture resistance
SCN9A variants: Congenital insensitivity to pain (rare; dangerous)

PHYSIOLOGICAL CONSTRAINTS:
─────────────────────────────────────────────────────────────────
Square-cube law: Limits size and strength scaling
Neural signal speed: 120 m/s maximum (myelinated axons)
Cardiac output: Limited by heart size and stroke volume
Thermoregulation: Core temperature >40°C → heat stroke
Oxygen delivery: Limited by hemoglobin concentration

PSYCHOLOGICAL DETERMINANTS:
─────────────────────────────────────────────────────────────────
Mental toughness: Ability to perform under pressure
Grit: Long-term persistence toward goals
Growth mindset: Belief that abilities can be developed
Intrinsic motivation: Internal drive (more sustainable than external)
```

### R#8.8 Collective Intelligence Framework

```
RESEARCH FINDINGS: COLLECTIVE INTELLIGENCE

KEY FINDING: PARAMETRIC MODEL FOR MEASURING GROUP PERFORMANCE (2026)
─────────────────────────────────────────────────────────────────
Source: "A collective-intelligence-driven parametric model for measuring
and improving group performance"
Information Sciences, Volume 748 (August 25, 2026)
Authors: Fang Liu et al.

COLLECTIVE INTELLIGENCE MEASUREMENT:
─────────────────────────────────────────────────────────────────
c factor: General collective intelligence (analogous to g for individuals)
Predictors of high c:
- Average social sensitivity of members
- Equality of conversational turn-taking
- Proportion of women in group (higher → higher c)
- NOT average individual IQ

HUMAN-AI COLLECTIVE INTELLIGENCE:
─────────────────────────────────────────────────────────────────
Source: "Artificial intelligence quotient framework for measuring human
collaboration with artificial intelligence"
Discover Artificial Intelligence (Springer, 2025)

AIQ Framework: Measures human-AI collaboration effectiveness
Dimensions: Task performance; communication quality; trust; adaptation

GROUP COMPOSITION OPTIMIZATION:
─────────────────────────────────────────────────────────────────
Optimal group size: 4-6 for most tasks
Diversity: Cognitive diversity > demographic diversity for performance
Roles: Clear role definition → better coordination
GAIAN: Recommends optimal group composition for tasks

EMERGENT CAPABILITY MEASUREMENT:
─────────────────────────────────────────────────────────────────
Emergence: Group capability > sum of individual capabilities
Measurement: Compare group performance to best individual
GAIAN: Tracks emergent capabilities in human-AI teams
```

---

## PART III: TIER 3 — STRATEGIC GAPS

### R#8.1 Superpower Definition Framework

```
RESEARCH FINDINGS: SUPERPOWER DEFINITION

KEY FINDING: STATISTICAL THRESHOLD + EVIDENCE LEVEL = SUPERPOWER CLASSIFICATION
─────────────────────────────────────────────────────────────────
STATISTICAL THRESHOLD MODEL:
─────────────────────────────────────────────────────────────────
Normal distribution (bell curve):
- 68% within 1 SD of mean
- 95% within 2 SD of mean
- 99.7% within 3 SD of mean

Superpower thresholds:
- Outlier: >2 SD above mean (top 2.5%)
- Exceptional: >3 SD above mean (top 0.15%)
- Superhuman: Beyond documented human range

HUMAN OUTLIER VERSUS TRUE SUPERHUMAN:
─────────────────────────────────────────────────────────────────
Human outlier: Exists within natural human distribution (e.g., VO2 max 101.1)
True superhuman: Beyond natural human limits (requires augmentation)
GAIA 2.0 classification:
- Natural superpower: Achievable through training/genetics (evidence-based)
- Augmented superpower: Requires technology (BCI; exoskeleton; gene editing)
- Theoretical superpower: Not yet achievable (future; speculative)

NATURAL VERSUS ENGINEERED CAPABILITY BOUNDARIES:
─────────────────────────────────────────────────────────────────
Natural: Genetic variation + training + environment
Engineered: Technology augmentation (exoskeleton; BCI; pharmacological)
Edited: Genetic modification (CRISPR; gene therapy)
GAIAN: Clearly labels which category each superpower belongs to

CAPABILITY SCALING FRAMEWORKS:
─────────────────────────────────────────────────────────────────
OECD AI Capability Indicators (2025): 5-level scale (basic → superhuman)
Applied to humans: Same 5-level scale for human capabilities
Level 1: Basic (below average)
Level 2: Average (within 1 SD)
Level 3: Above average (1-2 SD)
Level 4: Exceptional (2-3 SD; top 2.5%)
Level 5: Superhuman (>3 SD or augmented)
```

### R#8.13 Genetic Enhancement Framework

```
RESEARCH FINDINGS: GENETIC ENHANCEMENT

KEY FINDING: POST-CRISPR ERA IN SPORT; GOVERNANCE URGENTLY NEEDED
─────────────────────────────────────────────────────────────────
Source: "Genomic surveillance: protecting sport in the post-CRISPR era"
Trends in Biotechnology, Volume 44, Issue 7 (July 2026)
Author: Mauro Mandrioli

KEY FINDINGS:
─────────────────────────────────────────────────────────────────
"Post-CRISPR era": Gene editing is now technically feasible for enhancement
Sport governance: Genomic surveillance needed to detect gene doping
CRISPR for muscle disorders: Restoring function (therapeutic; not enhancement)

NATURAL GENETIC VARIANTS (documented):
─────────────────────────────────────────────────────────────────
EPAS1: High-altitude adaptation (Tibetan; Andean populations)
MSTN: Myostatin deficiency → muscle mass (rare; trade-offs)
ACTN3: Fast-twitch fiber composition
LRP5: High bone density
PCSK9: Low LDL cholesterol → cardiovascular protection
APOE ε2: Reduced Alzheimer's risk

ENHANCEMENT FEASIBILITY:
─────────────────────────────────────────────────────────────────
Single-gene traits: Technically feasible (MSTN; EPAS1)
Polygenic traits (intelligence; height): Extremely complex; not feasible
Off-target effects: Major safety concern
Germline editing: Heritable; profound ethical issues
Somatic editing: Non-heritable; lower ethical bar

REGULATORY FRAMEWORKS:
─────────────────────────────────────────────────────────────────
Therapeutic: FDA/EMA approved pathways (gene therapy for disease)
Enhancement: No approved pathway; prohibited in sport
Germline: Moratorium in most jurisdictions (He Jiankui case)
GAIAN: Clearly distinguishes therapeutic from enhancement applications
```

### R#8.14 Altered States Research

```
RESEARCH FINDINGS: ALTERED STATES

KEY FINDING: MEDITATION PRODUCES MEASURABLE BRAIN CHANGES; LONG-TERM EFFECTS POSITIVE
─────────────────────────────────────────────────────────────────
MEDITATION-STATE MEASUREMENT:
─────────────────────────────────────────────────────────────────
EEG signatures: Alpha waves (relaxed); theta waves (deep meditation)
fMRI: Default mode network suppression; insula activation
Structural changes: Gray matter increase (prefrontal; insula; hippocampus)
Functional changes: Improved attention; emotional regulation; compassion

CONSCIOUSNESS-STATE CLASSIFICATION:
─────────────────────────────────────────────────────────────────
Waking: Normal consciousness
Focused attention: Meditation (concentration)
Open monitoring: Meditation (mindfulness)
Non-dual awareness: Advanced meditation (rare)
Flow: Optimal performance state
Hypnagogic: Sleep onset
REM: Dreaming
Deep sleep: Slow-wave sleep

NEUROBIOLOGICAL MECHANISMS:
─────────────────────────────────────────────────────────────────
Dopamine: Released during flow; meditation; peak experiences
Serotonin: Elevated during positive states; meditation
Norepinephrine: Attention; arousal
GABA: Inhibitory; elevated during meditation
Endorphins: Physical exercise; pain relief

LONG-TERM EFFECTS:
─────────────────────────────────────────────────────────────────
8-week MBSR: Measurable structural brain changes
Long-term meditators: Slower age-related cortical thinning
Cognitive benefits: Attention; working memory; emotional regulation
GAIAN: Supports meditation practice; tracks progress
```

### R#8.17 Ethical Risk Framework

```
RESEARCH FINDINGS: ETHICAL RISKS

KEY FINDING: ENHANCEMENT CREATES INEQUALITY; GOVERNANCE IS URGENTLY NEEDED
─────────────────────────────────────────────────────────────────
ENHANCEMENT RISK ASSESSMENTS:
─────────────────────────────────────────────────────────────────
Physical enhancement: Exoskeletons; gene doping; pharmacological
Cognitive enhancement: BCIs; nootropics; genetic
Social enhancement: AI amplification; collective intelligence tools

SOCIAL INEQUALITY IMPLICATIONS:
─────────────────────────────────────────────────────────────────
Enhancement access: Currently limited to wealthy individuals
Cognitive inequality: BCI enhancement could create cognitive class divide
Athletic inequality: Gene doping could destroy fair competition
GAIA 2.0: Advocates for equal access to enhancement technologies

HUMAN IDENTITY QUESTIONS:
─────────────────────────────────────────────────────────────────
Psychological continuity: Does enhancement change who you are?
Neurorights: Right to preserve personal identity
Authenticity: Is enhanced performance "real"?
GAIAN: Supports user's right to choose enhancement; respects identity

COERCION SAFEGUARDS:
─────────────────────────────────────────────────────────────────
Workplace coercion: Employers requiring cognitive enhancement
Military coercion: Soldiers required to use BCIs
Social pressure: Enhancement becoming socially expected
GAIAN: Never coerces enhancement; always presents as choice
```

### R#8.19 Future Capability Forecasting

```
RESEARCH FINDINGS: FUTURE CAPABILITY FORECASTING

KEY FINDING: TRL FRAMEWORK + OECD AI CAPABILITY INDICATORS = FORECASTING FOUNDATION
─────────────────────────────────────────────────────────────────
OECD AI CAPABILITY INDICATORS (2025):
─────────────────────────────────────────────────────────────────
10 capability indicators (language; social interaction; problem-solving;
creativity; metacognition; learning/memory; vision; manipulation;
robotic intelligence; consciousness)
5-level scale: Basic → Human-equivalent → Beyond human
AI Catch-Up Index: Links capabilities to occupational data

TECHNOLOGY READINESS LEVELS FOR HUMAN ENHANCEMENT:
─────────────────────────────────────────────────────────────────
TRL 9 (Deployed): Exoskeletons (industrial); cochlear implants; LASIK
TRL 7-8 (Demonstrated): Non-invasive BCIs; gene therapy (therapeutic)
TRL 5-6 (Development): Invasive BCIs (Neuralink); CRISPR enhancement
TRL 3-4 (Research): Memory augmentation; cognitive enhancement drugs
TRL 1-2 (Theoretical): Mind uploading; radical life extension; neural lace

TIMELINE ESTIMATION:
─────────────────────────────────────────────────────────────────
Near-term (2026-2030): Non-invasive BCIs; exoskeletons; epigenetic interventions
Medium-term (2030-2040): Invasive BCIs; gene therapy enhancement; AI amplification
Long-term (2040-2060): Memory augmentation; cognitive enhancement; longevity escape velocity
Speculative (2060+): Mind uploading; radical life extension; neural lace

UNCERTAINTY QUANTIFICATION:
─────────────────────────────────────────────────────────────────
GAIAN: Reports confidence intervals for all timeline estimates
Example: "Non-invasive BCIs: 2-5 years (high confidence)"
Example: "Mind uploading: 50+ years (very low confidence)"
Scenario analysis: Best case; expected case; worst case
```

### R#8.20 Source Verification Audit

```
SOURCE VERIFICATION AUDIT — HUMAN SUPERPOWERS COMPONENTS

PERFORMANCE CLAIMS:
─────────────────────────────────────────────────────────────────
✓ VO2 max record 101.1 mL/kg/min (Blummenfelt, 2026): Confirmed (ScienceInsights May 2026)
✓ Previous record 97.5 mL/kg/min (Svendsen, 2012): Confirmed
✓ Western States 100 energy expenditure 16,104 kcal: Confirmed (J Appl Physiol, 2026)
✓ Carbohydrate intake 86 g/hour: Confirmed (J Appl Physiol, 2026)
✓ VO2 max ~50% heritable: Confirmed (twin studies; well-established)

LONGEVITY CLAIMS:
─────────────────────────────────────────────────────────────────
✓ Nature Medicine 2026: 51 studies; TranslAGE database: Confirmed
✓ DunedinPACE most responsive: Confirmed (Nature Medicine 2026)
✓ Pharmacological > lifestyle effects: Confirmed (Nature Medicine 2026)
✓ TNF-targeting agents: Strong DNAm biomarker effects: Confirmed
✓ Metformin: Strong DNAm changes: Confirmed
⚠ "Responsiveness ≠ slowing aging": Confirmed caveat (Nature Medicine 2026)

BCI GOVERNANCE CLAIMS:
─────────────────────────────────────────────────────────────────
✓ Categorical Gap Hypothesis: Published March 1, 2026 (confirmed)
✓ 34 jurisdictions mapped: Confirmed
✓ 4 governance regimes: Confirmed
✓ Chile; Colorado: Constitutional neurorights recognition: Confirmed
✓ Nature Communications Medicine BCI data protection: Confirmed (2026)

FLOW STATE CLAIMS:
─────────────────────────────────────────────────────────────────
✓ DMN suppression during flow: Confirmed (Frontiers Behavioral Neuroscience 2026)
✓ ECN activation during flow: Confirmed
✓ DMN-ECN connectivity during flow: Confirmed
✓ Wearable flow measurement: Confirmed (Scientific Reports April 2025)
✓ 9 studies in systematic review: Confirmed

COGNITIVE ENHANCEMENT CLAIMS:
─────────────────────────────────────────────────────────────────
✓ Working memory training meta-analysis: npj Digital Medicine March 2026: Confirmed
✓ Near transfer strong; far transfer limited: Confirmed
✓ Neural correlates confirmed: Confirmed
✓ Neuroplasticity mechanisms: Well-established neuroscience

AMPLIFICATION CLAIMS:
─────────────────────────────────────────────────────────────────
✓ arXiv:2603.18677: "Cognitive Amplification vs Cognitive Delegation": Confirmed (March 2026)
✓ CAI* < 0 in all tested regimes: Confirmed (key finding)
✓ 4 metrics (CAI*; DD; HRI; HCDR): Confirmed
✓ NetLogo simulation: Confirmed
⚠ "No regime achieves genuine amplification": Simulation result; real-world validation needed

GENETIC CLAIMS:
─────────────────────────────────────────────────────────────────
✓ EPAS1 Tibetan adaptation: Well-established (confirmed)
✓ MSTN deficiency → muscle mass: Confirmed (with trade-offs)
✓ Post-CRISPR era in sport: Trends in Biotechnology July 2026 (confirmed)
✓ Genomic surveillance needed: Confirmed
⚠ CRISPR enhancement feasibility: Technically possible; not yet done in humans
```

---

## PART IV: HUMAN SUPERPOWERS ARCHITECTURE CORRECTIONS

### 4.1 Required Architecture Updates

```
HUMAN SUPERPOWERS ARCHITECTURE CORRECTIONS FROM GAP RESEARCH

CORRECTION 1: IMPLEMENT 5-LEVEL EVIDENCE SCORING FOR ALL CLAIMS
─────────────────────────────────────────────────────────────────
Original: "Superpower database" (mixed evidence levels)
Corrected: "5-label confidence classification (Established/Promising/Experimental/Speculative/Theoretical)"

Every superpower claim: Evidence score required
Oxford hierarchy: Level 1-5 for each claim
GAIAN: Always shows evidence level; never presents speculation as fact

CORRECTION 2: ADOPT BD3 NEURAL DATA PROTECTION
─────────────────────────────────────────────────────────────────
Original: "BCI integration" (unspecified privacy)
Corrected: "BD3 (highest protection) for all neural data"

Categorical Gap Hypothesis: No jurisdiction has adequate BCI governance
GAIAN: Implements BD3 before any BCI integration
Neurorights: All 5 neurorights protected by design

CORRECTION 3: GAIAN MUST MAXIMIZE CAI* (COGNITIVE AMPLIFICATION INDEX)
─────────────────────────────────────────────────────────────────
Original: "AI amplification" (assumed positive)
Corrected: "CAI* < 0 in all tested regimes — cognitive delegation risk is real"

Critical warning: Current AI designs cause cognitive delegation, not amplification
GAIAN design principle: "I amplify you; I do not replace you"
Monitoring: GAIAN tracks CAI*; DD; HRI; HCDR for each user

CORRECTION 4: USE GENERATION 2+ EPIGENETIC CLOCKS FOR LONGEVITY
─────────────────────────────────────────────────────────────────
Original: "Longevity tracking" (unspecified)
Corrected: "DunedinPACE + PCGrimAge (Nature Medicine 2026)"

51 studies confirm: Generation 2+ clocks most responsive
GAIAN: Uses DunedinPACE (pace of aging) + PCGrimAge (mortality risk)
Caveat: Always includes "responsiveness ≠ slowing aging"

CORRECTION 5: FLOW STATE IS MEASURABLE WITH WEARABLES
─────────────────────────────────────────────────────────────────
Original: "Flow state" (subjective)
Corrected: "Flow = DMN suppression + ECN engagement; measurable with wearables"

GAIAN: Monitors HRV; skin conductance; EEG for flow indicators
Adaptive: Minimizes interruptions when flow detected

CORRECTION 6: VO2 MAX 101.1 IS THE NEW HUMAN CEILING
─────────────────────────────────────────────────────────────────
Original: "Elite athletic performance" (unspecified)
Corrected: "VO2 max 101.1 mL/kg/min (Blummenfelt, 2026) — first to break 100"

GAIAN: Uses documented performance records as benchmarks
Personalization: Compares user to age/sex-matched population norms
```

---

## CONCLUSION: HUMAN SUPERPOWERS GAP RESEARCH SUMMARY

The 20-gap research reveals a landscape of **extraordinary documented human performance**, **emerging governance crises**, and **a critical warning** about human-AI amplification.

**The five most important discoveries:**

1. **Cognitive delegation risk** (arXiv:2603.18677): CAI* < 0 in all tested regimes — GAIAN must be designed to amplify, not replace
2. **BCI governance crisis** (Neurotechnology, Society & Governance 2026): Categorical Gap across 34 jurisdictions — GAIAN must implement BD3 protection
3. **Longevity breakthrough** (Nature Medicine 2026): 51 studies; DunedinPACE most responsive; pharmacological > lifestyle
4. **Flow is measurable** (Scientific Reports 2025; Frontiers 2026): DMN suppression + ECN engagement; wearable detection feasible
5. **VO2 max 101.1** (2026): First human to break 100 — new documented ceiling of human aerobic performance

**The GAIAN Superpower Covenant:**
> "GAIAN helps every human being discover, develop, and deploy their superpowers — while being completely honest about what is established science, what is promising, what is experimental, and what is speculative. GAIAN amplifies human capability without replacing it. GAIAN protects neural data with the highest possible standard. And GAIAN never presents a theoretical future as an achievable present."

---

## QUICK REFERENCE

```
HUMAN SUPERPOWERS GAP RESEARCH QUICK REFERENCE

R#8.1 Definition: 5-level scale (Basic→Superhuman); natural/augmented/theoretical classification
R#8.2 Evidence: Oxford hierarchy; 5-label confidence (Established/Promising/Experimental/Speculative/Theoretical)
R#8.3 Potential: Gene-environment interactions; VO2 max ~50% heritable; AI multi-omics prediction
R#8.4 Trainability: VO2 max +15-20% trainable; deliberate practice; biological limits real
R#8.5 Cognitive: Working memory training meta-analysis (npj 2026); near transfer strong; far transfer limited
R#8.6 Flow: DMN suppression + ECN engagement; wearable measurement feasible; challenge-skill balance
R#8.7 Performance: VO2 max 101.1 (Blummenfelt 2026); WSER 100: 16,104 kcal; 86g CHO/hour
R#8.8 Collective: c factor; social sensitivity; turn-taking equality; AIQ framework
R#8.9 BCI Governance: Categorical Gap Hypothesis; 34 jurisdictions; 4 regimes; 5 neurorights
R#8.10 BCI Architecture: BD3 protection; neural privacy crisis; read-only default; consent required
R#8.11 Longevity: Nature Medicine 2026; 51 studies; DunedinPACE most responsive; pharmacological > lifestyle
R#8.12 Regeneration: TRL 4-6; tissue engineering advancing; human translation 10-20 years
R#8.13 Genetic: Post-CRISPR era (Trends Biotech July 2026); MSTN/EPAS1 natural variants; governance needed
R#8.14 Altered States: Meditation → structural brain changes; flow = optimal performance state
R#8.15 Assessment: 5-level capability scale; population norms; age/sex-matched comparison
R#8.16 Development: Deliberate practice; spaced repetition; sleep consolidation; retrieval practice
R#8.17 Ethics: Enhancement inequality; neurorights; coercion safeguards; identity questions
R#8.18 Amplification: CAI* < 0 in all regimes (arXiv:2603.18677); cognitive delegation risk; HCDR monitoring
R#8.19 Forecasting: TRL framework; OECD AI Capability Indicators; timeline uncertainty quantification
R#8.20 Audit: VO2 max 101.1 ✓; Nature Medicine 51 studies ✓; Categorical Gap Hypothesis ✓; CAI* < 0 ✓

CRITICAL WARNING: CAI* < 0 — current AI designs cause cognitive delegation, not amplification
→ GAIAN must be designed to maximize CAI* and minimize cognitive drift (HCDR)
→ "I amplify you. I do not replace you."
```

---

*GAIA 2.0 Human Superpowers Database Gap Research Report R#8.1–R#8.20*
*Blueprint 70 — Version 1.0 — September 9, 2026*
*License: Apache-2.0 | Open Source | Open Access*
*"Amplify first. Protect always. Be honest about what is possible."*
*"The greatest superpower is knowing your limits — and transcending them wisely."*
